Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginInterest Coverage RatioInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on SalesTimes Interest Earned

iBio (IBIO) Operating Margin (2016 - 2025)

Historic Operating Margin for iBio (IBIO) over the last 17 years, with Q3 2025 value amounting to 5951.0%.

  • iBio's Operating Margin changed N/A to 5951.0% in Q3 2025 from the same period last year, while for Dec 2025 it was 8491.0%, marking a year-over-year decrease of 43416700.0%. This contributed to the annual value of 4650.5% for FY2025, which is 27423900.0% up from last year.
  • As of Q3 2025, iBio's Operating Margin stood at 5951.0%.
  • Over the past 5 years, iBio's Operating Margin peaked at 377.11% during Q1 2022, and registered a low of 10206.0% during Q3 2023.
  • Over the past 5 years, iBio's median Operating Margin value was 2209.5% (recorded in 2024), while the average stood at 3597.2%.
  • Over the last 5 years, iBio's Operating Margin had its largest YoY gain of 32917600bps in 2021, and its largest YoY loss of -45314600bps in 2021.
  • iBio's Operating Margin (Quarter) stood at 6220.24% in 2021, then soared by 94bps to 377.11% in 2022, then crashed by -2606bps to 10206.0% in 2023, then surged by 78bps to 2209.5% in 2024, then plummeted by -169bps to 5951.0% in 2025.
  • Its Operating Margin stands at 5951.0% for Q3 2025, versus 2599.0% for Q2 2025 and 2209.5% for Q4 2024.